Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Kinesio Taping for Neurogenic Bowel Dysfunction in Spinal Cord Injury

10 juli 2026 bijgewerkt door: Meltem Gunes Akinci, Pamukkale University

Effectiveness of Kinesio Taping on Neurogenic Bowel Dysfunction in Individuals With Spinal Cord Injury: A Randomized Controlled Trial

Neurogenic bowel dysfunction is a common complication of spinal cord injury and may cause constipation, difficulty with defecation, prolonged bowel care, incomplete evacuation, fecal incontinence, and reduced quality of life. This randomized controlled trial aims to evaluate the effectiveness of Kinesio Taping added to a routine bowel management program in adults with spinal cord injury and upper motor neuron-type neurogenic bowel dysfunction.

Thirty participants will be randomly assigned to one of two parallel groups. The control group will receive a routine bowel management program, while the intervention group will receive Kinesio Taping in addition to the routine bowel management program. Kinesio Taping will be applied to the lower abdominal and lumbosacral regions three times per week for 4 weeks.

The primary outcome will be defecation frequency recorded using a 7-day bowel diary. Secondary outcomes will include stool consistency, defecation duration, perceived constipation severity, neurogenic bowel dysfunction severity, and health-related quality of life. Assessments will be performed before and after the 4-week intervention.

Studie Overzicht

Studietype

Ingrijpend

Inschrijving (Geschat)

30

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Studie Locaties

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • Adults aged 18 years or older with traumatic or nontraumatic spinal cord injury
  • Neurological level of injury at T12 or above
  • Upper motor neuron-type neurogenic bowel dysfunction
  • Duration of spinal cord injury longer than 6 months
  • Ability and willingness to provide written informed consent

Exclusion Criteria:

  • Age younger than 18 years
  • Neurological level of injury below T12
  • Gastrointestinal disease diagnosed before the spinal cord injury, including irritable bowel syndrome or inflammatory bowel disease
  • History of conservative treatment for neurogenic bowel dysfunction within the previous 6 months
  • Colostomy or history of bowel surgery
  • Neurological disease other than spinal cord injury that may cause gastrointestinal or anal sphincter dysfunction
  • Cognitive impairment that may interfere with participation in the study

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Actieve vergelijker: Routine Bowel Management Program
Participants in this arm will receive an individualized routine bowel management program based on their clinical condition for 4 weeks. The program may include scheduled bowel care, dietary and fluid recommendations, appropriate positioning, physical activity, abdominal massage, rectal evacuation techniques, suppositories, enemas, and oral or rectal laxatives when clinically indicated. Participants will be instructed not to change their usual dietary habits during the study period.
Participants will receive an individualized routine bowel management program based on their clinical condition for 4 weeks. The program may include scheduled bowel care, dietary and fluid recommendations, appropriate positioning, physical activity, abdominal massage, rectal evacuation techniques, suppositories, enemas, and oral or rectal laxatives when clinically indicated. Participants will be instructed not to change their usual dietary habits during the study period.
Experimenteel: Kinesio Taping Plus Routine Bowel Management Program
Participants in this arm will receive Kinesio Taping in addition to the routine bowel management program for 4 weeks. Kinesio Taping will be applied to the lower abdominal and lumbosacral regions three times per week by the same experienced physician. The tape will remain in place for 2 days and will be removed before the next treatment session. A star-shaped correction technique will be applied to the lumbosacral region with 25%-50% tension, and an I-shaped correction technique will be applied to the lower abdominal region between the right and left anterior superior iliac spines. No tension will be applied to the ends of the tape
Participants will receive an individualized routine bowel management program based on their clinical condition for 4 weeks. The program may include scheduled bowel care, dietary and fluid recommendations, appropriate positioning, physical activity, abdominal massage, rectal evacuation techniques, suppositories, enemas, and oral or rectal laxatives when clinically indicated. Participants will be instructed not to change their usual dietary habits during the study period.
Kinesio Taping will be applied to the lower abdominal and lumbosacral regions three times per week for 4 weeks. The tape will remain in place for 2 days and will be removed before the next treatment session. A star-shaped correction technique will be applied to the lumbosacral region with 25%-50% tension. An I-shaped correction technique will be applied to the lower abdominal region between the right and left anterior superior iliac spines. No tension will be applied to the ends of the tape.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Change in Defecation Frequency
Tijdsspanne: Baseline and at the end of the 4-week intervention
Defecation frequency will be recorded using a 7-day bowel diary and expressed as the total number of defecations during a 7-day period. Higher values indicate more frequent bowel movements.
Baseline and at the end of the 4-week intervention

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Change in Bristol Stool Form Scale Score
Tijdsspanne: Baseline and at the end of the 4-week intervention
Stool consistency will be assessed using the 7-point Bristol Stool Form Scale. Type 1 indicates separate hard lumps, while Type 7 indicates entirely liquid stool. Types 3 to 5 generally represent softer or more desirable stool consistency.
Baseline and at the end of the 4-week intervention
Change in Perceived Constipation Severity
Tijdsspanne: Baseline and at the end of the 4-week intervention
Participants will rate the overall severity of constipation on a 10-cm Visual Analog Scale ranging from 0 to 10. A score of 0 indicates no constipation, while a score of 10 indicates very severe constipation.
Baseline and at the end of the 4-week intervention
Change in Neurogenic Bowel Dysfunction Score
Tijdsspanne: Baseline and at the end of the 4-week intervention
Neurogenic bowel dysfunction severity will be assessed using the 10-item Neurogenic Bowel Dysfunction Score. The total score ranges from 0 to 47, with higher scores indicating more severe neurogenic bowel dysfunction.
Baseline and at the end of the 4-week intervention
Change in Short Form-36 Health Survey Scores
Tijdsspanne: Baseline and at the end of the 4-week intervention
Health-related quality of life will be assessed using the 36-item Short Form Health Survey. The instrument includes eight subscales, each scored from 0 to 100. Higher scores indicate better perceived health status.
Baseline and at the end of the 4-week intervention
Change in Defecation Duration
Tijdsspanne: Baseline and at the end of the 4-week intervention
Defecation duration will be recorded in minutes using a 7-day bowel diary. Participants will record the time required to complete each bowel evacuation. A shorter duration indicates less time spent on bowel care.
Baseline and at the end of the 4-week intervention
Change in the Feeling of Complete Evacuation
Tijdsspanne: Baseline and at the end of the 4-week intervention
The feeling of complete bowel evacuation will be recorded in the 7-day bowel diary after each defecation. The outcome will be expressed as the number or proportion of defecations associated with a feeling of complete evacuation during the 7-day assessment period. Higher values indicate more frequent complete evacuation.
Baseline and at the end of the 4-week intervention
Change in Straining During Defecation
Tijdsspanne: Baseline and at the end of the 4-week intervention
Straining during defecation will be recorded in the 7-day bowel diary. The outcome will be expressed as the number or proportion of defecations accompanied by straining during the 7-day assessment period. Lower values indicate less frequent straining.
Baseline and at the end of the 4-week intervention
Change in Painful Defecation
Tijdsspanne: Baseline and at the end of the 4-week intervention
Painful defecation will be recorded in the 7-day bowel diary. The outcome will be expressed as the number or proportion of defecations associated with pain during the 7-day assessment period. Lower values indicate less frequent painful defecation.
Baseline and at the end of the 4-week intervention

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

30 juli 2026

Primaire voltooiing (Geschat)

30 oktober 2026

Studie voltooiing (Geschat)

30 oktober 2026

Studieregistratiedata

Eerst ingediend

10 juli 2026

Eerst ingediend dat voldeed aan de QC-criteria

10 juli 2026

Eerst geplaatst (Werkelijk)

15 juli 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

15 juli 2026

Laatste update ingediend die voldeed aan QC-criteria

10 juli 2026

Laatst geverifieerd

1 juli 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren